Latest News & Features
Refine Search
Big Pharma
In November, the UK Supreme Court ruled that Warner-Lambert’s patent for a second medical use of pregabalin for the treatment of pain is invalid for insufficiency of disclosure. Sheena Linehan of Potter Clarkson explores the lessons for patent drafting. 28 November 2018
Americas
California-based FlexStent accused healthcare company Abbott Laboratories of infringing a stent patent earlier this week, with the filing of a lawsuit at the US District Court for the Central District of California. 28 November 2018
Americas
The US Food and Drug Administration is set to change the way that medical devices are approved, after 42 years. 27 November 2018
Biotechnology
Despite the importance of IP rights to biotech and biopharma innovation, recent decisions and new policies are weakening and reducing the scope of IP-based incentives, according to a report. 27 November 2018
Asia-Pacific
India-based drug company Sun Pharma has made further inroads into the Japanese market with the planned acquisition of Pola Pharma. 26 November 2018
Big Pharma
The EU General Court dismissed Canada-based Endoceutics’ trademark appeal in a win for medical technology company Merck KGaA on Thursday, November 22. 26 November 2018
Asia-Pacific
Scientists have urged policymakers to implement a regulatory framework governing the use of CRISPR technology in humans, following reports that a Chinese scientist has successfully created ‘edited’ twins. 26 November 2018
Biotechnology
The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month. 23 November 2018
Americas
Saul Ewing Arnstein & Lehr has strengthened its Boston office with the addition of two life sciences partners from Hamilton, Brook, Smith & Reynolds. 23 November 2018
Americas
The US Court of Appeals for the Federal Circuit vacated a preliminary injunction against India-based Dr Reddy’s earlier this week, in a blow for addiction treatment drug producer Indivior. 22 November 2018